“…However, these methods typically identify only strong binders, cannot return negative information about residues that ablate binding critical for downstream target prediction in vivo (Gfeller et al, 2011), and do not directly probe effects of PTMs. Array-based methods (Fodor et al, 1991) allow quantification of binding of labeled proteins to 10s-100s (SPOT arrays) (Frank et al, 1990), tens of thousands (Atwater et al, 2018), or millions (ultra-high density arrays) (Buus et al, 2012; Forsström et al, 2014; Price et al, 2012; Carmona et al, 2015) of peptides chemically synthesized in situ , permitting direct incorporation of PTMs or unnatural amino acids at specific positions (Engelmann et al, 2014; Tinti et al, 2013; Filippakopoulos et al, 2012). However, it is difficult to evaluate the yield and purity of peptides in each spot, contributing to false positives and negatives (Tinti et al, 2013; Blikstad and Ivarsson, 2015).…”